| Name | Title | Contact Details |
|---|
EnteroMedics® Inc. is the developer of vBloc® neurometabolic therapy, delivered by a pacemaker-like device called the Maestro® Rechargeable System, a first-in-class weight loss treatment for obesity and obesity related risk factors, such as high blood pressure or high cholesterol levels. vBloc Therapy is a non-anatomy altering or restricting, reversible therapy that allows patients to safely lose weight by helping patients feel less hungry, reduce the amount of food eaten at a meal, and feel full longer in between meals. vBloc Therapy is now approved by the Food and Drug Administration for weight loss in adults with a BMI of 40 to 45 kg/m2 or a BMI of 35 to 39.9 kg/m2 with a related health condition such as high blood pressure or high cholesterol levels.* *Individuals should have first tried to lose weight by diet and exercise in a supervised program within the last 5 years before receiving the Maestro System.
OrthoPediatrics Corp is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Senior Marketing Manager is a Markham, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Only Amedica has developed the technology to create medical grade silicon nitride ceramic; a material that, compared to others on the market, promises spinal implants with excellent osteoconductive properties, higher wear resistance, and greatly improved compatibility with MRI, fluoroscopy and CT imaging systems.
Pethealth Inc. is a Oakville, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.